Van Spall, Harriette
( McMaster University
, Hamilton
, Ontario
, Canada
)
Author Disclosures:
Harriette Van Spall:DO have relevant financial relationships
;
Consultant:Astra Zeneca:Active (exists now)
; Consultant:Novo Nordisk:Active (exists now)
; Consultant:Roche:Active (exists now)
; Other (please indicate in the box next to the company name):Novartis - Educational Account:Past (completed)
; Consultant:Medtronic:Active (exists now)
; Other (please indicate in the box next to the company name):Medtronic - Clinical Trial Executive Committee Role:Active (exists now)
; Research Funding (PI or named investigator):Heart and Stroke Foundation of Canada:Past (completed)
; Other (please indicate in the box next to the company name):Colorado Prevention Center Clinical Research - Clinical Trial Executive Committee Role:Active (exists now)
; Other (please indicate in the box next to the company name):CardioVascular Research Foundation - Clinical Trial Events Committee:Active (exists now)
; Research Funding (PI or named investigator):Canadian Institutes of Health Research:Active (exists now)
; Other (please indicate in the box next to the company name):Boehringer Ingelheim Pharmaceuticals, Inc - Educational Account:Past (completed)
; Consultant:Bayer:Active (exists now)
; Other (please indicate in the box next to the company name):Bayer - Advisory Board:Active (exists now)
; Consultant:Baim Institute for Clinical Research:Active (exists now)